Scanvio
Scanvio Medical is an ETH Zurich spin-off founded in 2024 that develops AI-augmented ultrasound software to enable faster and more reliable diagnosis of endometriosis. Their flagship product, Scanvio AI Assistant™, integrates AI technology to provide real-time feedback and guidance during transvaginal ultrasound exams, helping gynecologists visualize and diagnose endometriosis effectively with existing ultrasound equipment. The solution aims to reduce diagnosis time from 8-12 years to 1-3 years, democratizing expert ultrasound skills and establishing a new medical standard for ultrasound-based endometriosis diagnosis. Scanvio targets clinicians, endometriosis centers, and ultrasound manufacturers, offering software add-ons to improve diagnostic accuracy, standardize reporting, and support personalized treatment and surgical planning. The company has received multiple grants and awards, including support from Venture Kick and the Future of Health Grant, and participates in the NVIDIA Inception program, reflecting strong traction and recognition in the medtech and AI health sectors.
Scanvio
Scanvio Medical is an ETH Zurich spin-off founded in 2024 that develops AI-augmented ultrasound software to enable faster and more reliable diagnosis of endometriosis. Their flagship product, Scanvio AI Assistant™, integrates AI technology to provide real-time feedback and guidance during transvaginal ultrasound exams, helping gynecologists visualize and diagnose endometriosis effectively with existing ultrasound equipment. The solution aims to reduce diagnosis time from 8-12 years to 1-3 years, democratizing expert ultrasound skills and establishing a new medical standard for ultrasound-based endometriosis diagnosis. Scanvio targets clinicians, endometriosis centers, and ultrasound manufacturers, offering software add-ons to improve diagnostic accuracy, standardize reporting, and support personalized treatment and surgical planning. The company has received multiple grants and awards, including support from Venture Kick and the Future of Health Grant, and participates in the NVIDIA Inception program, reflecting strong traction and recognition in the medtech and AI health sectors.